Previous close | 10.40 |
Open | 11.10 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 490.00 |
Expiry date | 2024-09-20 |
Day's range | 10.30 - 11.10 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On May 22, 2024, Bruce Sachs, Director at Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 7,073 shares of the company.
On May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 15,202 shares of the company, according to the SEC Filing.
BOSTON, May 22, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.